Specialty chemicals company Lanxess has increased its dichlorobenzene capacity by more than 15%. It has done so by installing an additional crystallizer at the Leverkusen site, thereby enabling it to produce more high-purity para-dichlorobenzene for the global market.
Some €3 million has been invested in the capacity expansion for this intermediate for the manufacture of high-performance plastics.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
BASF sells a majority stake in its coatings business to the investor Carlyle.
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
Merck to acquire the chromatography business of JSR Life Sciences, a leading provider of CDMO services, preclinical and translational clinical research, and bioprocessing solutions.
Compelling solutions through strategic partnerships
